raloxifene hydrochloride has been researched along with Venous Thromboembolism in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Shieh, Y; Tice, JA | 1 |
| González-RodrĂguez, A; Seeman, MV | 1 |
| Lee, CH; Lin, SJ; Lin, TC; Yang, CY; Yang, YH | 1 |
| Abramson, BL; Amewou-Atisso, M; Barrett-Connor, E; Collins, P; Dowsett, SA; Geiger, MJ; Grady, D; Kornitzer, M; Mosca, L; Paganini-Hill, A; Wenger, N | 1 |
| de Villiers, TJ | 1 |
| Mosekilde, L; Pinholt, EM; Rejnmark, L; Schwartz, K; Vestergaard, P | 1 |
| Becker, C | 1 |
| Cox, DA; Duvernoy, CS; Kim, HM; Wong, M; Yeo, AA | 1 |
| Abildgaard, U; Andresen, MS; Eilertsen, AL; Sandset, PM | 1 |
| Kluft, C | 1 |
| Adomaityte, J; Farooq, M; Qayyum, R | 1 |
5 review(s) available for raloxifene hydrochloride and Venous Thromboembolism
| Article | Year |
|---|---|
Medications for Primary Prevention of Breast Cancer.
Topics: Anticarcinogenic Agents; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Primary Prevention; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Uterine Neoplasms; Venous Thromboembolism | 2020 |
Pharmacotherapy for schizophrenia in postmenopausal women.
Topics: Antipsychotic Agents; Female; Humans; Phytoestrogens; Postmenopause; Raloxifene Hydrochloride; Receptors, Estrogen; Schizophrenia; Venous Thromboembolism | 2018 |
Clinical issues regarding cardiovascular disease and selective estrogen receptor modulators in postmenopausal women.
Topics: Cardiovascular Diseases; Female; Humans; Indoles; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Factors; Selective Estrogen Receptor Modulators; Stroke; Tamoxifen; Tetrahydronaphthalenes; Venous Thromboembolism | 2009 |
Effects of hormone treatment on hemostasis variables.
Topics: Administration, Oral; Administration, Topical; Dose-Response Relationship, Drug; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Hemostasis; Humans; Inflammation; Norpregnenes; Progestins; Raloxifene Hydrochloride; Tamoxifen; Venous Thromboembolism | 2007 |
Effect of raloxifene therapy on venous thromboembolism in postmenopausal women. A meta-analysis.
Topics: Aged; Bone Density Conservation Agents; Female; Humans; Middle Aged; Odds Ratio; Osteoporosis, Postmenopausal; Patient Selection; Postmenopause; Pulmonary Embolism; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Selective Estrogen Receptor Modulators; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis | 2008 |
3 trial(s) available for raloxifene hydrochloride and Venous Thromboembolism
| Article | Year |
|---|---|
Effect of raloxifene on stroke and venous thromboembolism according to subgroups in postmenopausal women at increased risk of coronary heart disease.
Topics: Comorbidity; Coronary Artery Disease; Humans; Incidence; Middle Aged; Mortality; Postmenopause; Raloxifene Hydrochloride; Risk Assessment; Risk Factors; Selective Estrogen Receptor Modulators; Smoking; Stroke; Treatment Outcome; Venous Thromboembolism | 2009 |
Antiplatelet therapy use and the risk of venous thromboembolic events in the Raloxifene Use for the Heart (RUTH) trial.
Topics: Aspirin; Cohort Studies; Coronary Disease; Double-Blind Method; Female; Humans; Middle Aged; Placebos; Platelet Aggregation Inhibitors; Postmenopause; Proportional Hazards Models; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Treatment Outcome; Venous Thromboembolism | 2010 |
Hormone therapy and raloxifene reduce the coagulation inhibitor potential.
Topics: Aged; Blood Coagulation; Estrogen Antagonists; Estrogen Replacement Therapy; Factor V; Female; Fibrin; Heterozygote; Humans; Middle Aged; Mutation; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Risk Factors; Thrombophilia; Venous Thromboembolism | 2007 |
3 other study(ies) available for raloxifene hydrochloride and Venous Thromboembolism
| Article | Year |
|---|---|
Incidence and risk of venous thromboembolism among Taiwan osteoporotic fracture population under osteoporosis pharmacological treatments.
Topics: Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Calcitonin; Female; Humans; Incidence; Male; Middle Aged; Osteoporosis; Osteoporotic Fractures; Raloxifene Hydrochloride; Retrospective Studies; Risk; Taiwan; Venous Thromboembolism | 2014 |
Use of bisphosphonates and raloxifene and risk of deep venous thromboembolism and pulmonary embolism.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Denmark; Diphosphonates; Dose-Response Relationship, Drug; Epidemiologic Methods; Female; Humans; Male; Middle Aged; Organometallic Compounds; Osteoporosis; Pulmonary Embolism; Raloxifene Hydrochloride; Thiophenes; Venous Thromboembolism | 2010 |
Another selective estrogen-receptor modulator for osteoporosis.
Topics: Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Coronary Disease; Female; Fractures, Bone; Humans; Osteoporosis, Postmenopausal; Pyrrolidines; Raloxifene Hydrochloride; Risk; Selective Estrogen Receptor Modulators; Spinal Fractures; Stroke; Tamoxifen; Tetrahydronaphthalenes; Venous Thromboembolism | 2010 |